Tech Company Financing Transactions

Ception Therapeutics Funding Round

EW Healthcare Partners, Aperture Venture Partners and Investor Growth Capital participated in a $63 million Series C capital raise for Ception Therapeutics. The round was announced on 1/31/2007.

Transaction Overview

Company Name
Ception Therapeutics
Announced On
1/31/2007
Transaction Type
Venture Equity
Amount
$63,000,000
Round
Series C
Investors

EW Healthcare Partners (Lead Investor) (Jeffrey Himawan)

Aperture Venture Partners

Investor Growth Capital (Liza Page Nelson)

MDS Capital (Brian Underdown)

New Science Ventures

Proceeds Purpose
Ception Therapeutics will use the proceeds from the transaction primarily to advance its late-stage biologic anti-inflammatory programs and to pursue further progression of a small molecule anti-TNF program and several other discovery programs.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
101 Lindenwood Dr. 400
Malvern, PA 19355
USA
Phone
(610) 640-2940
Website
www.ceptiontx.com
Email Address
[email protected]
Overview
Ception Therapeutics is an emerging biopharmaceutical company focused on the discovery and development of novel products to address areas of unmet medical need.
Profile
Ception Therapeutics LinkedIn Company Profile
Social Media
Ception Therapeutics Company Twitter Account
Company News
Ception Therapeutics News
Facebook
Ception Therapeutics on Facebook
YouTube
Ception Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stephen Tullman
  Stephen Tullman LinkedIn Profile  Stephen Tullman Twitter Account  Stephen Tullman News  Stephen Tullman on Facebook
Chief Financial Officer
Doug Gessl
  Doug Gessl LinkedIn Profile  Doug Gessl Twitter Account  Doug Gessl News  Doug Gessl on Facebook
Vice President
Jeffrey Wilkins
  Jeffrey Wilkins LinkedIn Profile  Jeffrey Wilkins Twitter Account  Jeffrey Wilkins News  Jeffrey Wilkins on Facebook
VP - Bus. Development
Kelly Copeland
  Kelly Copeland LinkedIn Profile  Kelly Copeland Twitter Account  Kelly Copeland News  Kelly Copeland on Facebook
VP - Operations
Evan Dick
  Evan Dick LinkedIn Profile  Evan Dick Twitter Account  Evan Dick News  Evan Dick on Facebook
VP - Product Management
Jeffrey Shaver
  Jeffrey Shaver LinkedIn Profile  Jeffrey Shaver Twitter Account  Jeffrey Shaver News  Jeffrey Shaver on Facebook
VP - R & D
Tim Henkel
  Tim Henkel LinkedIn Profile  Tim Henkel Twitter Account  Tim Henkel News  Tim Henkel on Facebook
VP - Regulatory Affairs
Patricia Cleveland
  Patricia Cleveland LinkedIn Profile  Patricia Cleveland Twitter Account  Patricia Cleveland News  Patricia Cleveland on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/31/2007: Aprio Technologies venture capital transaction
Next: 1/31/2007: Rally Software venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.